Cited by

• Update on cardiovascular disease in lupus.

  Lewandowski LB, Kaplan MJ. Lewandowski LB, et al. Curr Opin Rheumatol. 2016 Sep;28(5):468-76. doi: 10.1097/BOR.0000000000000307. Curr Opin Rheumatol. 2016. PMID: 27227346 Free PMC article. Review.
• Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.

  Reiss AB, Arain HA, Kasselman LJ, Renna HA, Zhen J, Voloshyna I, DeLeon J, Carsons SE, Petri M. Reiss AB, et al. Medicina (Kaunas). 2019 Aug 21;55(9):514. doi: 10.3390/medicina55090514. Medicina (Kaunas). 2019. PMID: 31438615 Free PMC article.
• Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.

  Hasni S, Temesgen-Oyelakin Y, Davis M, Chu J, Poncio E, Naqi M, Gupta S, Wang X, Oliveira C, Claybaugh D, Dey A, Lu S, Carlucci P, Purmalek M, Manna ZG, Shi Y, Ochoa-Navas I, Chen J, Mukherjee A, Han KL, Cheung F, Koroleva G, Belkaid Y, Tsang JS, Apps R, Thomas DE, Heller T, Gadina M, Playford MP, Li X, Mehta NN, Kaplan MJ. Hasni S, et al. Ann Rheum Dis. 2022 Oct 12;81(11):1576-1584. doi: 10.1136/ard-2022-222658. Ann Rheum Dis. 2022. PMID: 35914929 Free PMC article.
• Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population.

  Chen SK, Barbhaiya M, Fischer MA, Guan H, Lin TC, Feldman CH, Everett BM, Costenbader KH. Chen SK, et al. Arthritis Care Res (Hoboken). 2019 Jan;71(1):104-115. doi: 10.1002/acr.23574. Arthritis Care Res (Hoboken). 2019. PMID: 29648687 Free PMC article.